Reversibility of retinal ischemia due to central retinal artery occlusion by hyperbaric oxygen

Reversibility of retinal ischemia due to central retinal artery occlusion by hyperbaric oxygen

Ischemic retinal damage can be reversed by hyperbaric oxygen therapy (HBOT) as long as irreversible infarction damage has not developed. However, the time window till irreversible damage develops is still unknown. The study aim was to evaluate the effect of HBOT and determine possible markers for ir...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical ophthalmology (Auckland, N.Z.) N.Z.), 2017-01, Vol.11, p.115-125
Hauptverfasser: Hadanny, Amir, Maliar, Amit, Fishlev, Gregory, Bechor, Yair, Bergan, Jacob, Friedman, Mony, Avni, Isaac, Efrati, Shai
Format: Artikel
Sprache:eng
Schlagworte:
Analysis
Care and treatment
Central Retinal Artery Occlusion
Cherry red spot
CRAO
Diabetes
Diabetic retinopathy
FDA approval
HBOT
Hyperbaric Oxygen
Hyperbaric oxygenation
Ischemia
Medicine
Ophthalmology
Original Research
Oxygen therapy
Patient outcomes
Patients
Retinal diseases
retinal ischemia
Studies
Ulcers
Veins & arteries
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Ischemic retinal damage can be reversed by hyperbaric oxygen therapy (HBOT) as long as irreversible infarction damage has not developed. However, the time window till irreversible damage develops is still unknown. The study aim was to evaluate the effect of HBOT and determine possible markers for irreversible retinal damage. Retrospective analysis of 225 patients treated with HBOT for central retinal artery occlusion (CRAO) in 1999-2015. One hundred and twenty-eight patients fulfilled inclusion/exclusion criteria: age >18 years, symptoms
ISSN:1177-5467
1177-5483
1177-5483
DOI:10.2147/OPTH.S121307